Oncolytics Biotech Management
Management criteria checks 2/4
Oncolytics Biotech's CEO is Matt Coffey, appointed in Jan 2016, has a tenure of 8.25 years. total yearly compensation is CA$2.25M, comprised of 32.7% salary and 67.3% bonuses, including company stock and options. directly owns 1.97% of the company’s shares, worth CA$2.21M. The average tenure of the management team and the board of directors is 5.2 years and 6.4 years respectively.
Key information
Matt Coffey
Chief executive officer
CA$2.2m
Total compensation
| CEO salary percentage | 32.7% |
| CEO tenure | 8.3yrs |
| CEO ownership | 2.0% |
| Management average tenure | 5.2yrs |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Feb 23
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?
Nov 10We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Jul 07Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?
Mar 24Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?
Dec 09We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate
Aug 25Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
May 12We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth
Dec 02We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth
Aug 05Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth
Apr 15We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Dec 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CA$2m | CA$735k | -CA$28m |
| Sep 30 2023 | n/a | n/a | -CA$32m |
| Jun 30 2023 | n/a | n/a | -CA$27m |
| Mar 31 2023 | n/a | n/a | -CA$24m |
| Dec 31 2022 | CA$1m | CA$654k | -CA$25m |
| Sep 30 2022 | n/a | n/a | -CA$24m |
| Jun 30 2022 | n/a | n/a | -CA$24m |
| Mar 31 2022 | n/a | n/a | -CA$27m |
| Dec 31 2021 | CA$2m | CA$637k | -CA$26m |
| Sep 30 2021 | n/a | n/a | -CA$28m |
| Jun 30 2021 | n/a | n/a | -CA$30m |
| Mar 31 2021 | n/a | n/a | -CA$29m |
| Dec 31 2020 | CA$1m | CA$541k | -CA$23m |
| Sep 30 2020 | n/a | n/a | -CA$33m |
| Jun 30 2020 | n/a | n/a | -CA$29m |
| Mar 31 2020 | n/a | n/a | -CA$28m |
| Dec 31 2019 | CA$965k | CA$525k | -CA$33m |
| Sep 30 2019 | n/a | n/a | -CA$19m |
| Jun 30 2019 | n/a | n/a | -CA$18m |
| Mar 31 2019 | n/a | n/a | -CA$17m |
| Dec 31 2018 | CA$2m | CA$475k | -CA$17m |
| Sep 30 2018 | n/a | n/a | -CA$17m |
| Jun 30 2018 | n/a | n/a | -CA$17m |
| Mar 31 2018 | n/a | n/a | -CA$17m |
| Dec 31 2017 | CA$726k | CA$430k | -CA$16m |
Compensation vs Market: Matt's total compensation ($USD1.64M) is above average for companies of similar size in the Canadian market ($USD174.90K).
Compensation vs Earnings: Matt's compensation has increased whilst the company is unprofitable.
CEO
Matt Coffey
8.3yrs
Tenure
CA$2,246,023
Compensation
Dr. Matthew C. Coffey, also known as Matt, Ph D., M.B.A., Co-founded Oncolytics Biotech Inc., and has been its Chief Executive Officer since 2016 and President since January 19, 2017. He has been a Directo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.3yrs | CA$2.25m | 1.97% CA$ 2.2m | |
| Chief Financial Officer | 11.4yrs | CA$1.32m | 1.18% CA$ 1.3m | |
| Chief Medical Officer | 2.3yrs | CA$1.36m | 0.68% CA$ 769.1k | |
| Vice President of Product Development | 5.5yrs | CA$727.64k | 0.69% CA$ 769.9k | |
| Vice President of Clinical Operations | 1.3yrs | CA$683.55k | no data | |
| Director of Investor Relations & Communication | no data | no data | no data | |
| Consultant | 4.9yrs | CA$25.98k | no data |
5.2yrs
Average Tenure
Experienced Management: ONC's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 12.9yrs | CA$2.25m | 1.97% CA$ 2.2m | |
| Independent Director | 8.8yrs | CA$123.96k | 0.50% CA$ 566.4k | |
| Independent Director | 1.8yrs | CA$116.36k | 0.060% CA$ 67.1k | |
| Independent Director | 1.7yrs | CA$107.40k | 0.060% CA$ 67.1k | |
| Independent Chairman of the Board | 10.9yrs | CA$165.01k | 0.35% CA$ 394.8k | |
| Independent Director | 9.8yrs | CA$130.58k | 0.26% CA$ 286.8k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.4yrs | CA$124.95k | 0.15% CA$ 170.2k | |
| Member of Scientific Advisory Board | 6.4yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data |
6.4yrs
Average Tenure
67.5yo
Average Age
Experienced Board: ONC's board of directors are considered experienced (6.4 years average tenure).